Status: current, Primitive. Date: 31-Jan 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3506885018 | Saxagliptin hydrochloride (substance) | en | Fully specified name | Active | Case insensitive | SNOMED CT core |
| 3506886017 | Saxagliptin hydrochloride | en | Synonym | Active | Case insensitive | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Saxagliptin hydrochloride | Is a | Saxagliptin | false | Inferred relationship | Some | ||
| Saxagliptin hydrochloride | Has disposition | Dipeptidyl peptidase IV inhibitor | true | Inferred relationship | Some | ||
| Saxagliptin hydrochloride | Is a | Substance with alcohol structure | true | Inferred relationship | Some | ||
| Saxagliptin hydrochloride | Is modification of | Saxagliptin | true | Inferred relationship | Some | ||
| Saxagliptin hydrochloride | Is a | Dipeptidyl peptidase IV inhibitor | true | Inferred relationship | Some | ||
| Saxagliptin hydrochloride | Is a | Nitrile | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Saxagliptin (as saxagliptin hydrochloride) 2.5 mg oral tablet | Has precise active ingredient | True | Saxagliptin hydrochloride | Inferred relationship | Some | 1 |
| Saxagliptin (as saxagliptin hydrochloride) 5 mg oral tablet | Has precise active ingredient | True | Saxagliptin hydrochloride | Inferred relationship | Some | 1 |
| Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 2.5 mg prolonged-release oral tablet | Has precise active ingredient | True | Saxagliptin hydrochloride | Inferred relationship | Some | 2 |
| Metformin hydrochloride 500 mg and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet | Has precise active ingredient | True | Saxagliptin hydrochloride | Inferred relationship | Some | 2 |
| Metformin hydrochloride 1 g and saxagliptin (as saxagliptin hydrochloride) 5 mg prolonged-release oral tablet | Has precise active ingredient | True | Saxagliptin hydrochloride | Inferred relationship | Some | 2 |
Reference Sets
Substance foundation reference set
FHIR